Tech Talk

Keep in touch with the top industry topics.

Do Particulates Matter…? 9 recalls in USA already this year suggest they do!

Tuesday the 10th June 2014

By: John Johnson

The visual appearance of sterile drug products is obviously a key quality attribute for any formulated product, yet the pharma industry still struggles to define, control and set in place effective monitors. Freedom from particulates has been a compendial requirement for three decades so why is ...

Read more

Data Integrity

Wednesday the 12th March 2014

By: Maxine Fritz, EVP of NSF Health Sciences Pharma Biotech, George Toscano, Senior Director of Quality Systems, Pharmaceuticals, Biotech and Biologics, and Darren Jones, Consultant, NSF Health Sciences Pharma Biotech

Make sure this hot topic doesn’t burn you … or your suppliers, contract manufacturers or contract laboratories

How confident are you that there are no data integrity issues within your firm, or within the many suppliers, contract laboratories or contract manufacturers you use in the developmen...

Read more

The Qualified Person In The New European Regulation

Tuesday the 3rd December 2013

By: James Pink

This brief article outlines the new EU requirement for a “Qualified Person” (QP) which is contained in the EU Regulation due to replace the current medical devices Directives 93/42/EEC and 90/385/EEC. The new Regulation has been the subject of fierce debate between the various stakeholders throu...

Read more

Preparing for Unannounced Inspections From Notified Bodies for Medical Devices

Friday the 8th November 2013

By: James Pink, VP Europe-Health Sciences Medical Devices at NSF International

Europe has introduced further measures for unannounced audits of manufacturers by notified bodies. With this in mind, James Pink, VP Europe-Health Sciences Medical Devices at NSF International, provides a little help to prepare for them.


There are two important documents that are ...

Read more

How to Prepare for the ICH Q3D Elemental Impurities Guideline

Monday the 9th September 2013

By: Janeen Skutnik, Vice President at NSF Health Sciences, Pharma Biotech.

The upcoming implementation of the International Conference on Harmonisation’s ICH Q3D Guideline for Elemental Impurities and the United States Pharmacopeia (USP)’s General Chapters for Elemental Impurities has triggered its fair share of concern and uncertainty. Some of this is due to the unkno...

Read more

Quick links

NSF Health Sciences have offices in Kirkbymoorside and Sheffield, UK and Boston and Ann Arbor, USA

A word from NSF Health Sciences

The NSF Health Sciences team make an effort to keep in touch with industry best practice and like to explore the key topics that are hot in the industry. We are always interested in your views so please feel free to tell us what you think about our Tech Talk articles here and in the Journal.

Martin Lush

© NSF Health Sciences 2014

Registered Office: NSF Health Sciences, The Georgian House, 22/24 West End, Kirkbymoorside, York, UK, YO62 6AF
Registered in England and Wales No: 3432550 | Tel: +44(0)1751 432999 | Fax: +44(0)1751 432450 | Email:
US Office: NSF Health Sciences, 6th floor, 129 South St, Boston, MA 02111 | Tel: 1-857-277-0060 | Fax: 1-857-284-7207 | Email: